We are pleased to announce that the OBN Awards has shortlisted Precision for Medicine, Oncology and Rare Disease as a finalist for Best Specialist CRO!

As knowledge around biomarkers grows, more drugs are coming onto the market with FDA-approved labels indicating their use with a particular diagnostic test. With most manufacturers nowadays choosing not to develop their own companion diagnostics but rather to partner with an outside firm, pharma companies need to be able to […]